Allevion Therapeutics
PrivateLast Round
VC Round
Sep 23, 2020
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Allevion Therapeutics operates in Healthcare & Life Sciences and is based in Irvine, California. Its latest recorded funding round was a VC Round in September 2020.
Allevion Therapeutics is a health care company that develops non-invasive, wearable neuromodulation devices for the treatment of movement disorders such as essential tremor.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Health IoT, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Allevion Therapeutics Comparables
Compare Allevion Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Encora Therapeutics | 89% | |
| Fasikl, Inc. | 84% | |
| Cala Health | 82% |
For institutional investors. Book with your work email.
Allevion Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Sep 23, 2020 | ||||
| Series A | Jul 9, 2019 | ||||
| Seed | May 9, 2018 |
For institutional investors. Book with your work email.
Allevion Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Adventus Ventures | VC Round, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors increased 2833% to 1.3K.
- Sep 23, 2020
Adventus Ventures participated in the VC Round.
For institutional investors. Book with your work email.
Allevion Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Allevion Therapeutics's valuation, stock price, and market status.
Is Allevion Therapeutics a public or private company?
Allevion Therapeutics is a private company.
What is the current stock price of Allevion Therapeutics?
Allevion Therapeutics is a private company, so its shares have no public market price. Caplight tracks Allevion Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Allevion Therapeutics worth (valuation)?
Valuation information for Allevion Therapeutics is not publicly available.
Can I buy Allevion Therapeutics stock?
Allevion Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Allevion Therapeutics's last funding round?
Allevion Therapeutics's most recent funding round was VC Round on September 23, 2020.
Who are the main investors in Allevion Therapeutics?
Key investors in Allevion Therapeutics include Adventus Ventures.
Will Allevion Therapeutics IPO soon?
No public IPO plans have been announced for Allevion Therapeutics.
How can I track Allevion Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Allevion Therapeutics's shares on secondary markets.